About GelSana
GelSana is a Healthcare company based in Aurora (United States) founded in 2020 by Melissa Krebs. Novel hydrogels for wound healing and therapeutic delivery are developed. GelSana has raised $4.16 million across 5 funding rounds from investors including HHS, Mines and Innosphere Ventures. The company has 4 employees. Its chief executive, as recorded, is Melissa Krebs. GelSana offers products and services including Elastic Wound Dressings. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its legal entity is GELSANA THERAPEUTICS INC. Its competitors include Alafair Biosciences, Contraline and Octet Medical; 3 of its 3 listed competitors have raised funding.
Company details
GelSana was founded in 2020 in Aurora, United States, within the biotechnology sector. Novel hydrogels are developed for wound healing applications. A bio-inert adhesive delivery system has been created to enable controlled release of therapeutics. Wound closure is accelerated and healing is supported through this approach, while inflammatory responses are minimized. Operations center on advancing hydrogel-based solutions for medical use.
- Headquarters Aurora, United States
- Employees 4
- Founders Melissa Krebs
- SectorsHealthcare
- Email••••••••
- Website gelsanatherapeutics.com
- Social LinkedIn
- Legal Name Gelsana Therapeutics Inc
- Total Equity Funding$4.16M (USD)
in 5 rounds
- Latest Funding Round$324.99K (USD), Grant
Sep 2024
- InvestorsHHS
& 4 more
- Employee Count4
Products & Services of GelSana
GelSana offers a comprehensive portfolio of products and services, including Elastic Wound Dressings.
Dressings that reduce inflammation, prevent infection, and deliver drugs for wound healing.
Funding Insights of GelSana
GelSana has successfully raised a total of $4.16M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $324.99 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.16M
- Total Rounds 5
- Last Round Grant — $324,992
- First Round $250,000
(Nov 2021)
- Investors Count 5
All 5 funding rounds of GelSana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $324,992 | Grant | – | – | |
| Nov 2023 | $2.81M | Series A | – | Innosphere Ventures | |
| Apr 2023 | $299,650 | Grant | – | – | |
| May 2022 | $1.35M | Seed | – | Innosphere Ventures | – |
| Nov 2021 | $250,000 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in GelSana
GelSana has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Mines and Innosphere Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| innosphereventures.org | ||||
Early-stage investments are made in innovative companies by Innosphere Ventures. | 2017 | innospherefund.com | Boulder, USA | |
| cobioscience.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Multiple courses and degrees are offered across diversified streams. | 1951 | mines.edu | United States |
Investor details for GelSana
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GelSana
10 people are tracked at GelSana (3 in leadership, 6 in board & advisors, 1 in team); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Melissa Krebs | Founder & CEO | Leadership |
Adam Rocker | R&d Director | Leadership |
Ania Camplin | Fractional CFO | Leadership |
Jim Kasic | Board Member | Board & advisors |
Joanna Money | Business Development Advisor | Board & advisors |
David Armstrong | Clinical Advisor | Board & advisors |
Mike Freeman | Board Member | Board & advisors |
Larry Blankenship | Regulatory & Design Advisor | Board & advisors |
John James | Clinical Advisor | Board & advisors |
Gabbie Codino | Project Manager | Team |
Complete people profiles for GelSana
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GelSana
3 dated milestones of GelSana across 4 years, from founding to its latest funding, stage changes and deals.
- Founded GelSana is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Grant, of $325K.
Competitors of GelSana
GelSana has 3 listed competitors in our database, 3 of them funded. They include Alafair Biosciences, Contraline and Octet Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alafairbiosciences.com | 2011 | Austin, United States | $13.74M | Biomaterials and devices for internal wound healing are developed. | ||
| contraline.com | 2015 | Charlottesville, United States | $18.62M | 7 | Contraline is focused on developing innovative male contraception solutions. | |
| octetmedical.com | 2018 | San Diego, United States | $10M | Medical devices for wound dressing and closure are provided. |
Detailed competitors of GelSana
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
3 companies that operate in the same segment as GelSana (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gelsana
Complete news archive for GelSana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GelSana
GelSana was founded in 2020 and raised its 1st funding round 1 year after it was founded.
GelSana is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Melissa Krebs is the CEO of GelSana, as recorded in our data. They have also founded this company.
GelSana is a funded company, having raised a total of $4.16M across 5 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Nov 2021.
GelSana has 4 employees.
GelSana was founded in 2020 in Aurora, United States, within the biotechnology sector. Novel hydrogels are developed for wound healing applications. A bio-inert adhesive delivery system has been created to enable controlled release of therapeutics. Wound closure is accelerated and healing is supported through this approach, while inflammatory responses are minimized. Operations center on advancing hydrogel-based solutions for medical use.
GelSana's top competitors include Alafair Biosciences, Contraline and Octet Medical.
GelSana offers Elastic Wound Dressings.
GelSana has 5 investors. Key investors include HHS, Mines, Innosphere Ventures, Innosphere Ventures, and CBSA.
GelSana operates through Gelsana Therapeutics Inc.